T he researched, largely funded by the charity Breast Cancer Now and published in Nature Communications, revealed that anakinra is able to prevent breast cancer by forming secondary tumors in the bone.
Follow treatment with anakinra 14% of mice in the study develop secondary tumors in bone compared to 42% of control animals.
Breast cancer is most commonly spread to bone, brain, lung, or liver.
Baroness Delit Morgan, Chief Executive Officer of Breast Cancer Now Said: "These major findings offer another promising step forward in the reassignment of existing drugs to prevent the spread of breast cancer.
"While more research is needed, it is really exciting that well-tolerated and widely available arthritis drugs can help prevent secondary breast cancer in the bone. "
Lead author Dr Rachel Ayr of the University of Manchester says:" We are very excited by our results in the lab showing that
"We hope to find out soon whether these drugs can be used for patients with breast cancer after successful tests in clinical trials. "